Skip to main content
Clinical Trials/CTRI/2012/12/003273
CTRI/2012/12/003273Recruiting未知

A open label, randomized controlled trial of Artesunate Sulfadoxine- Pyrimethamine (AS-SP) vs Artesunate - Sulfadoxine-Pyrimethamine + Primaquine (AS-SP+PQ) for decreasing malaria transmission in India - ACT+PQ

ational Institute of Malaria Research New Delhi0 sites250 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Recruiting
Sponsor
Enrollment
250

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Open enrollment of any uncomplicated PF patient regardless of the gametocyte status, including mixed infections. This provides a stronger trial design given the operational simplicity, fewer assumptions, and greater generalizability of results

Exclusion Criteria

  • Signs of severe malaria, history of previous antimalarial intake within < 1 week, children <1 year, and G6PD deficient patients will be excluded from the study.

Investigators

Sponsor
ational Institute of Malaria Research New Delhi

Similar Trials